Back to search

D-cycloserine does not enhance exposure–response prevention therapy in obsessive–compulsive disorder

Data up to Jan 2025

Published2007
Citations200
References33

Total Citations Per Year

Abstract

References (33)

The Yale-Brown Obsessive Compulsive Scale

1989 • 7,156 citations

Emotional processing of fear: Exposure to corrective information.

1986 • 4,816 citations

The Yale-Brown Obsessive Compulsive Scale

1989 • 2,646 citations

The Obsessive-Compulsive Inventory: Development and validation of a short version.

2002 • 2,612 citations

Mechanisms of fear extinction

2006 • 1,214 citations

Cognitive Enhancers as Adjuncts to Psychotherapy

2004 • 1,058 citations

A Multidimensional Model of Obsessive-Compulsive Disorder

2005 • 1,019 citations

Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-Amygdala Infusions of d-Cycloserine as Assessed with Fear-Potentiated Startle in Rats

2002 • 807 citations

Understanding and treating obsessive—compulsive disorder

1999 • 682 citations

Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder

2006 • 559 citations

Symptom Presentation and Outcome of Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder.

2003 • 464 citations

Effects of D-cycloserine on extinction of conditioned freezing.

2003 • 384 citations

Psychometric properties and construct validity of the Obsessive–Compulsive Inventory—Revised: Replication and extension with a clinical sample

2006 • 367 citations

Consolidation of Extinction Learning Involves Transfer from NMDA-Independent to NMDA-Dependent Memory

2001 • 363 citations

d-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction

2005 • 242 citations

Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions.

2003 • 230 citations

The Obsessive-Complusive Inventory: Development and validation of a short version.

2002 • 227 citations

Pharmacotherapy of Obsessive-compulsive Disorder and Obsessive-Compulsive Spectrum Disorders

2006 • 202 citations

D-Cycloserine and the Facilitation of Extinction of Conditioned Fear: Consequences for Reinstatement.

2004 • 190 citations

A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear

2006 • 160 citations

Cognitive-Behavioral Therapy for Medication Nonresponders With Obsessive-Compulsive Disorder

2004 • 154 citations

Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy*

2002 • 153 citations

d-Cycloserine enhances implicit memory in Alzheimer patients

1996 • 150 citations

Effects of multiple exposures to d-cycloserine on extinction of conditioned fear in rats

2005 • 146 citations

D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response.

2006 • 134 citations

Improved Cognition in Alzheimer’s Disease With Short-Term D-Cycloserine Treatment

1999 • 130 citations

A Randomized Clinical Trial of Cognitive-Behavioral Group Therapy and Sertraline in the Treatment of Obsessive-Compulsive Disorder

2006 • 115 citations

A randomized controlled trial of the effect of d-cycloserine on extinction and fear conditioning in humans

2006 • 105 citations

Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures

1993 • 69 citations

Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited

2005 • 60 citations

Combining pharmacotherapy with cognitive behavioral therapy: Traditional and new approaches

2006 • 56 citations

Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence

2000 • 55 citations

Pharmacotherapies in the Management of Obsessive—Compulsive Disorder

2006 • 47 citations

Cited By (0)

Loading...